SBT1.6 Antibody

Potential Nomenclature Confusion

The designation "SBT1.6" does not align with established antibody nomenclature systems (e.g., WHO’s INN system) or widely recognized research antibodies. Closest matches include:

SBT-Labeled Antibodies

Antibodies prefixed with "SBT" typically originate from Singh Biotechnology (e.g., SBT-100, SBT-102). These are camelid-derived single-domain antibodies (sdAbs) targeting intracellular oncoproteins like KRAS and STAT3 . No "SBT1.6" is documented in their pipeline.

Subtilase Family (SBT1-6)

In plant biology, SBT1-6 refers to subtilase enzymes, not antibodies. For example:

• SBT5.2 modulates transcriptional activation pathways in Arabidopsis .

• No antibodies targeting these enzymes are described in the reviewed literature.

Hypothetical Characterization

If "SBT1.6 Antibody" exists in an undisclosed context, its properties might align with established antibody classes:

Recommendations for Clarification

1. Verify nomenclature for typos (e.g., SBT-1.6 vs. SBT1.6).

2. Explore proprietary databases or unpublished industry data.

3. Contact developers of SBT-labeled antibodies (e.g., Singh Biotechnology) for pipeline updates.